Bladerunner, Here is some information that misspinkard may like if you would want to post it on that cancer patient website to her. First I am long Neoprobe so yes I am a pumper but the Rigs technology works and I believe in it. Here is the survival data that was performed on stage 4 patients. An independent clinical research organization performed a survival analysis based on the patients enrolled in NEO2-14, the pivotal clinical study that served as the primary evidence submitted to the FDA in 1997 as the basis for the Company's Biologic License Application (BLA). Ninety-four of 109 evaluable patients determined by the FDA were available for analysis. The study found the five-year mortality rates for the following:
91% mortality for those patients diagnosed with positive spread of disease without the aid of RIGS (Traditional+) 53% mortality for those patients diagnosed with positive spread of disease with the aid of RIGS positive but were otherwise traditionally negative( RIGS+/traditional-)
25% mortality for those patients who have no evidence of spread of disease with the aid of RIGS (RIGS-/Traditional-) Source: Schneebaum et. al., Budapest 2004
Neoprobe could get a CMA, allows patients to get the surgery while the trials are going on, in Europe as early as Q4 of 2009/Q1-2010 so she may want to keep her eye on this technology if she still has colon cancer. Here is a blog that has more info on Neoprobe and Rigs. http://www.investorvillage.com/blog.asp?b=3A649286B78CB5E9
News 
Market Data 
Discover 
AI
